Screening for prostate cancer with prostate-specific antigen is not routinely performed in any of the EPIC countries, although testing for prostate cancer by using the serum concentration of prostate-specific antigen (PSA) has become more widely used during the follow-up period of the present study. Here, KLK3 is linked to prostate cancer.